Nektar Therapeutics (NKTR) EPS (Weighted Average and Diluted) Growth (3y) (2016 - 2026)
Nektar Therapeutics (NKTR) EPS (Weighted Average and Diluted) Growth (3y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
59.54% |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
22,777.33% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
1,857.10% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
41.33% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
14.33% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Nektar Therapeutics |
1.51 Bn |
939.55 Mn |
3.16 Mn |
-35.60% |
| Date | Value |
|---|
| Mar 31, 2026 |
-35.60% |
| Dec 31, 2025 |
-70.64% |
| Sep 30, 2025 |
-82.04% |
| Jun 30, 2025 |
-51.40% |
| Mar 31, 2025 |
-94.76% |
| Dec 31, 2024 |
26.01% |
| Sep 30, 2024 |
-56.05% |
| Jun 30, 2024 |
-75.97% |
| Mar 31, 2024 |
34.62% |
| Dec 31, 2023 |
30.31% |
| Sep 30, 2023 |
26.72% |
| Jun 30, 2023 |
15.66% |
| Mar 31, 2023 |
2.18% |
| Dec 31, 2022 |
20.63% |
| Sep 30, 2022 |
17.89% |
| Jun 30, 2022 |
-10.50% |
| Mar 31, 2022 |
10.78% |
| Dec 31, 2021 |
-1,014.94% |
| Sep 30, 2021 |
-7.72% |
| Jun 30, 2021 |
-28.65% |
